SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 474,315.86 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 143,486.00 |
| Book Value / Share | 42.65 |
| Price / Book | n/a |
| NCAV ($M) | -161,412.00 |
| NCAV / Share | -47.98 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.39 |
| Return on Assets (ROA) | 0.32 |
| Return on Equity (ROE) | 0.95 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.55 |
| Current Ratio | 0.74 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 160,897.00 |
| Assets | 465,795.00 |
| Liabilities | 322,309.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 290,403.00 |
| Operating Income | 134,039.00 |
| Net Income | 100,988.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 120,968.00 |
| Cash from Investing | -128,895.00 |
| Cash from Financing | 8,735.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| NEXI – NexImmune, Inc. | NMTRQ – 9 Meters Biopharma, Inc. |
| NNMX – Nanomix Corporation | NPHC – Nutra Pharma Corp. |
| NPNKF – Nippon Shinyaku Co., Ltd. |
Financial data and stock pages provided by
Fintel.io